Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 451-460 of 10439

Edit search filters
  1. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

    Rochester, MN

  3. A Study in Second Line Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of Lusedra (Fospropofol Disodium) for Use as Minimal to Moderate Sedation for Regional Anesthesia Nerve Blockage Prior to Orthopedic Surgery

    Scottsdale/Phoenix, AZ

  5. A Study Comparing Orteronel Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer, who have not had Chemotherapy

    Jacksonville, FL, Rochester, MN

  6. Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1

    Rochester, MN

  7. Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

    Rochester, MN

  8. Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility

  9. A Study of Simvastatin Therapy for Moderate and Severe COPD

    Rochester, MN

  10. Vitamin D Supplementation in Breastfeeding Women

    Rochester, MN

.

Mayo Clinic Footer